subject: DRUGBANK:DB16738

subject_name: Ciltacabtagene autoleucel

object_name: Plasma cell myeloma refractory


subject: DRUGBANK:DB16738

object_name: Relapse multiple myeloma

tested_intervention: unsure


subject: UNII:4W3KFI3TN3

subject_name: Talquetamab


subject: UMLS:C4687984

subject_name: talquetamab


subject: CHEBI:59224

subject_name: Cetrorelix

object_name: Subfertility


subject: UNII:W9Y8L7GP4C

subject_name: Cetrotide


subject: CHEBI:94534

subject_name: olanzapine

object_name: Huntington disease

tested_intervention: yes


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: undifferentiated pancreatic carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: undifferentiated carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: clear cell adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: mucinous adenocarcinoma


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Primary Peritoneal Transitional Cell Carcinoma


subject: CHEBI:175901

object_name: Primary Peritoneal Undifferentiated Carcinoma


subject: CHEBI:175901

object_name: primary peritoneal serous adenocarcinoma


subject: CHEBI:175901

object_name: peritoneal serous adenocarcinoma


subject: CHEBI:175901

object_name: Undifferentiated Fallopian Tube Carcinoma


subject: CHEBI:175901

object_name: Clear cell adenocarcinoma of peritoneum


subject: CHEBI:175901

object_name: fallopian tube transitional cell carcinoma


subject: CHEBI:175901

object_name: fallopian tube clear cell adenocarcinoma


subject: CHEBI:175901

object_name: Primary Peritoneal Endometrioid Adenocarcinoma


subject: CHEBI:175901

object_name: ovarian transitional cell carcinoma


subject: CHEBI:175901

object_name: fallopian tube serous adenocarcinoma


subject: CHEBI:175901

object_name: fallopian tube mucinous adenocarcinoma


subject: CHEBI:175901

object_name: fallopian tube endometrioid adenocarcinoma


subject: CHEBI:175901

object_name: ovarian Brenner tumor


subject: CHEBI:175901

object_name: undifferentiated ovarian carcinoma


subject: CHEBI:175901

object_name: undifferentiated pancreatic carcinoma


subject: CHEBI:175901

object_name: undifferentiated carcinoma


subject: CHEBI:175901

object_name: ovarian clear cell adenocarcinoma


subject: CHEBI:175901

object_name: ovarian endometrioid adenocarcinoma


subject: CHEBI:175901

object_name: ovarian clear cell malignant adenofibroma


subject: CHEBI:175901

object_name: ovarian seromucinous carcinoma


subject: CHEBI:175901

object_name: ovarian serous adenocarcinoma


subject: CHEBI:175901

object_name: clear cell adenocarcinoma


subject: CHEBI:175901

object_name: mucinous adenocarcinoma


subject: CHEBI:124917

subject_name: Rabusertib

object_name: Advanced cancer


subject: CHEBI:28887

subject_name: Ofatumumab

object_name: pemphigus vulgaris


subject: UMLS:C1541395


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Failed conscious sedation during procedure


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:8802

subject_name: Remifentanil


subject: CHEBI:3077

subject_name: Betamethasone

object_name: Acquired trigger finger


subject: CHEBI:3077

object_name: trigger thumb


subject: CHEBI:9123

subject_name: Sertraline

object_name: Inflammation


subject: CHEBI:9943

subject_name: Venlafaxine


subject: MESH:C117343

subject_name: red yeast rice

object_name: hyperlipidemia


subject: PUBCHEM.COMPOUND:67439664

subject_name: Atovaquone/proguanil

object_name: disease transmission


subject: UMLS:C0939219

subject_name: atovaquone / proguanil


subject: CHEBI:91231

subject_name: Piperaquine


subject: PUBCHEM.COMPOUND:65404

subject_name: fanasil, pyrimethamine drug combination


subject: UMLS:C0700599

subject_name: pyrimethamine / sulfadoxine


subject: UNII:7DM27RQ9V0

object_name: prostate carcinoma


subject: UNII:7DM27RQ9V0

object_name: prostate cancer


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Acute appendicitis NOS (disorder)


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: fallopian tube carcinoma


subject: UNII:6A901E312A

object_name: fallopian tube cancer


subject: UNII:6A901E312A

object_name: primary peritoneal carcinoma


subject: UNII:6A901E312A

object_name: Primary Peritoneal Cancer


subject: UNII:TDX7IXK9CU

object_name: pancreatitis


subject: UNII:TDX7IXK9CU

object_name: Pancreatitis, CTCAE 5.0


subject: UNII:TDX7IXK9CU

object_name: Pancreatitis, CTCAE 3.0


subject: CHEBI:29228

subject_name: FLUORIDE

object_name: Dental Plaque


subject: CHEBI:17051

subject_name: Fluoride ion


subject: UMLS:C3541971

subject_name: Fluoride supplements


subject: UMLS:C3714616

subject_name: Fluoride Drug Class


subject: CHEBI:194135

subject_name: Ofloxacin

object_name: Acute otitis media


subject: CHEBI:9728

subject_name: Trimethaphan

object_name: Supine hypertension


subject: CHEBI:9728

object_name: orthostatic hypotension


subject: UMLS:C4525531

object_name: thyroid gland papillary carcinoma


subject: UMLS:C4525531

object_name: Myofibromatosis


subject: UMLS:C4525531

object_name: congenital fibrosarcoma


subject: UMLS:C4525531

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C4525531

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C4525531

object_name: sarcoma


subject: UMLS:C4525531

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C4525531

object_name: soft tissue sarcoma


subject: UNII:CEGM9YBNGD

subject_name: Selpercatinib


subject: UNII:CEGM9YBNGD


subject: UNII:CEGM9YBNGD


subject: UNII:CEGM9YBNGD


subject: UNII:CEGM9YBNGD


subject: UNII:CEGM9YBNGD


subject: UNII:CEGM9YBNGD


subject: CHEBI:22972

subject_name: butyryl group

object_name: multidrug-resistant tuberculosis


subject: CHEBI:22927

subject_name: bromine atom


subject: CHEBI:22925

subject_name: bromide salt


subject: UMLS:C3467978


subject: GTOPDB:12347

subject_name: penpulimab

object_name: liver carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297571

subject_name: PENPULIMAB


subject: CHEBI:132244

subject_name: (E)-3-(indol-3-yl)acrylic acid

object_name: adult acute myeloid leukemia


subject: CHEBI:132244

object_name: childhood acute myeloid leukemia


subject: CHEBI:132244

object_name: acute myeloid leukemia


subject: CHEBI:74062

subject_name: Ile-Ala


subject: CHEBI:74062


subject: CHEBI:74062


subject: CHEBI:3374

subject_name: Capsaicin

object_name: facial pain


subject: CHEBI:3374

object_name: Facial Pain, CTCAE


subject: CHEBI:50634

object_name: cysticercosis


subject: CHEBI:50634

object_name: Neurocysticercosis


subject: CHEBI:50634

object_name: Central Nervous System Cysticercosis


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEBI:27690


subject: CHEBI:27690


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:64356

object_name: Anesthesia morbidity


subject: CHEBI:64356

object_name: urinary system disorder


subject: CHEBI:64356

object_name: no feeling or sensation of skin


subject: CHEBI:64356

object_name: Sensory Loss


subject: PUBCHEM.COMPOUND:58291210

subject_name: Oligofructose

object_name: irritable bowel syndrome


subject: MESH:C120489

subject_name: oligofructose


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: dilated cardiomyopathy


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified


subject: UNII:7XL5ISS668

object_name: Recurrent Follicular Helper T-Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: Refractory Follicular Helper T-Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: Recurrent Follicular Helper T-Cell Lymphoma, Follicular-Type


subject: UNII:7XL5ISS668

object_name: Peripheral T-cell lymphoma unspecified refractory


subject: UNII:7XL5ISS668

object_name: Recurrent Hepatosplenic T-Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: Angioimmunoblastic T-cell lymphoma recurrent


subject: UNII:7XL5ISS668

object_name: Refractory Follicular Helper T-Cell Lymphoma, Follicular-Type


subject: UNII:7XL5ISS668

object_name: Intestinal T-cell lymphoma recurrent


subject: UNII:7XL5ISS668

object_name: Refractory Hepatosplenic T-Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: Angioimmunoblastic T-cell lymphoma refractory


subject: UNII:7XL5ISS668

object_name: Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: Intestinal T-cell lymphoma refractory


subject: UNII:7XL5ISS668

object_name: Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: MESH:D000082082

subject_name: Immune Checkpoint Inhibitors

object_name: Hodgkin Disease


subject: MESH:D000082082

object_name: Adult Hodgkin Lymphoma


subject: MESH:D000082082

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:31547

subject_name: Eplerenone

object_name: atrial fibrillation


subject: CHEBI:31547

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:31547

object_name: Atrial Fibrillation, CTCAE


subject: UNII:MJ95C3OH47

subject_name: olive leaf extract

object_name: type 2 diabetes mellitus


subject: UNII:MJ95C3OH47

object_name: Diabetes


subject: UNII:MJ95C3OH47

object_name: diabetes mellitus


subject: UMLS:C4310555

object_name: gonorrhea


subject: UNII:953A26OA1Y

subject_name: Dornase alfa

object_name: otitis media


subject: UNII:953A26OA1Y

object_name: infectious otitis media


subject: UNII:953A26OA1Y

object_name: Otitis Media, CTCAE


subject: PR:000006592


subject: PR:000006592


subject: PR:000006592


subject: UMLS:C0251564

subject_name: Pulmozyme


subject: UMLS:C0251564


subject: UMLS:C0251564


subject: CHEBI:35493

subject_name: antipyretic

object_name: glycogen storage disease III


subject: UMLS:C0003419

subject_name: Antipyretics


subject: UMLS:C0019592

subject_name: Histamine H1 Antagonists


subject: UMLS:C0019593

subject_name: Histamine H2 Antagonists


subject: UMLS:C5853620


subject: UMLS:C1699394

subject_name: Hylenex

object_name: superficial urinary bladder carcinoma


subject: CHEBI:6801

subject_name: Metformin

object_name: Refractory Neoplasm


subject: CHEBI:6801

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:6801

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:6801

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:91450

subject_name: Sapanisertib


subject: CHEBI:91450


subject: CHEBI:91450


subject: CHEBI:40279

subject_name: Allopurinol

object_name: Mania, CTCAE


subject: CHEBI:40279

object_name: Mania


subject: CHEBI:40279

object_name: bipolar disorder


subject: UMLS:C5239121

subject_name: Enadenotucirev-expressing FAP/CD3 Bispecific FAP-TAc NG-641

object_name: Epithelioma


subject: UMLS:C5239121

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5239121

object_name: Embolism, Tumor


subject: UMLS:C5239121

object_name: Neoplasm Metastasis


subject: UNII:L93WSG9AAU


subject: UNII:L93WSG9AAU


subject: UNII:L93WSG9AAU


subject: UNII:L93WSG9AAU


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: psoriatic arthritis


subject: UNII:6029HGL0QP

subject_name: fluorocholine

object_name: prostate carcinoma


subject: UNII:6029HGL0QP

object_name: prostate cancer


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib

object_name: Secondary Central Nervous System Lymphoma


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: UNII:6ZZ3B7NZ0B

subject_name: THELIATINIB

object_name: cancer


subject: UNII:6ZZ3B7NZ0B

object_name: neoplasm


subject: UMLS:C5206642

subject_name: Xiliertinib


subject: UMLS:C5206642


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: cardiovascular disorder


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:38940

subject_name: Sunitinib

object_name: Secondary malignant neoplasm of lung


subject: UNII:7P55415B0R

object_name: multiple sclerosis


subject: UMLS:C2830067

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:11670360

subject_name: Nirogacestat


subject: UNII:9H4570Q89D

subject_name: Pleconaril

object_name: enterovirus infectious disease


subject: PUBCHEM.COMPOUND:3370

subject_name: Fludrocortisone acetate


subject: PUBCHEM.COMPOUND:3370

object_name: prostate neoplasm


subject: CHEBI:50885

subject_name: Fludrocortisone


subject: CHEBI:50885


subject: CHEBI:16962

subject_name: Cortisone


subject: CHEBI:16962


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: PUBCHEM.COMPOUND:135151902

subject_name: OPEVESOSTAT


subject: PUBCHEM.COMPOUND:135151902


subject: DRUGBANK:DB18818

subject_name: Opevesostat


subject: DRUGBANK:DB18818


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: embryonal rhabdomyosarcoma


subject: CHEBI:4026

object_name: Metastatic rhabdomyosarcoma


subject: CHEBI:4026

object_name: spindle cell rhabdomyosarcoma


subject: CHEBI:4026

object_name: Solid Alveolar Rhabdomyosarcoma


subject: CHEBI:4026


subject: CHEBI:4026

object_name: Metastatic embryonal rhabdomyosarcoma


subject: CHEBI:4026

object_name: botryoid rhabdomyosarcoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:125400

subject_name: actinomycin D


subject: CHEBI:125400


subject: CHEBI:125400


subject: CHEBI:125400


subject: CHEBI:125400


subject: CHEBI:125400


subject: CHEBI:125400


subject: CHEBI:27666

subject_name: Dactinomycin


subject: CHEBI:27666


subject: CHEBI:27666


subject: CHEBI:27666


subject: CHEBI:27666


subject: CHEBI:27666


subject: CHEBI:27666


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:32296

subject_name: vinorelbine L-tartrate


subject: CHEBI:32296

object_name: Childhood Embryonal Rhabdomyosarcoma


subject: CHEBI:32296


subject: CHEBI:32296


subject: CHEBI:32296


subject: CHEBI:32296


subject: CHEBI:32296


subject: CHEBI:32296

object_name: childhood botryoid rhabdomyosarcoma


subject: CHEBI:32296


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: CHEBI:53750

subject_name: vinorelbine D-tartrate


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: PUBCHEM.COMPOUND:75988815

subject_name: Elafibranor

object_name: primary biliary cholangitis


subject: PUBCHEM.COMPOUND:5245480

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:5245480

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:5245480

object_name: breast cancer


subject: CHEBI:30703

subject_name: Tetrathiomolybdate


subject: CHEBI:30703


subject: CHEBI:30703


subject: RXCUI:352990

subject_name: Suboxone

object_name: opioid use


subject: CHEBI:91424

object_name: cancer


subject: CHEBI:91424

object_name: neoplasm


subject: MESH:C581956


subject: MESH:C581956


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Advanced breast cancer


subject: UMLS:C5200971

subject_name: Decitabine for Injection

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5200971

object_name: acute myeloid leukemia


subject: UMLS:C5200971

object_name: Myelodysplasia


subject: UMLS:C5206898

subject_name: Venclyxto


subject: UMLS:C5206898


subject: UMLS:C5206898


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: coronary restenosis


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:94461

subject_name: Celiprolol

object_name: chronic obstructive pulmonary disease


subject: UMLS:C5555019

subject_name: Anti-OX40/CD137 Bispecific Antibody FS120

object_name: Advanced cancer


subject: UMLS:C5555019

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5555019

object_name: Embolism, Tumor


subject: UMLS:C5555019

object_name: Neoplasm Metastasis


subject: PUBCHEM.COMPOUND:23667621

subject_name: DEXAMETHASONE SODIUM PHOSPHATE

object_name: ataxia telangiectasia


subject: UNII:D6OMY2L0WA

subject_name: Epcoritamab

object_name: Follicular lymphoma refractory


subject: UMLS:C5206892

subject_name: epcoritamab


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous


subject: CHEBI:31485

subject_name: Difluprednate

object_name: Bacterial keratitis


subject: CHEBI:63611

subject_name: Moxifloxacin


subject: UNII:BIU7Q7W2SH

subject_name: Rose Bengal B


subject: CHEBI:87202

subject_name: Rose bengal


subject: CHEBI:52261

subject_name: rose bengal


subject: UMLS:C4086994

object_name: Kaposi Sarcoma


subject: UMLS:C3273725


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Intraoperative blood loss


subject: UMLS:C0592155

subject_name: Syntocinon


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Advanced Soft Tissue Sarcoma


subject: CHEBI:72317

object_name: undifferentiated pleomorphic sarcoma


subject: CHEBI:72317

object_name: Childhood Undifferentiated Pleomorphic Sarcoma


subject: UMLS:C4308782

object_name: Crohn disease


subject: CHEBI:50731

subject_name: morphine sulfate pentahydrate

object_name: Arthritis of knee


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Estrogen Receptor Positive


subject: PUBCHEM.COMPOUND:70789204

object_name: Refractory Hormone Receptor-Positive Breast Carcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Stage IIIC Breast Cancer AJCC v7


subject: PUBCHEM.COMPOUND:70789204

object_name: Progesterone Receptor Positive


subject: PUBCHEM.COMPOUND:70789204

object_name: HER2 positive


subject: PUBCHEM.COMPOUND:70789204

object_name: Stage IIIA Breast Carcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Stage IIIB Breast Carcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Breast cancer recurrent


subject: PUBCHEM.COMPOUND:70789204

object_name: Refractory Breast Carcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Postmenopausal


subject: PUBCHEM.COMPOUND:70789204

object_name: Premenopausal symptoms


subject: PUBCHEM.COMPOUND:70789204

object_name: Premenopausal


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: CHEBI:135966

subject_name: Carisbamate

object_name: focal epilepsy


subject: CHEBI:135966

object_name: epilepsy


subject: UMLS:C0936150

subject_name: artemether / lumefantrine

object_name: Pregnant


subject: UMLS:C0936150

object_name: Premature birth


subject: UMLS:C0936150

object_name: Light for dates


subject: UMLS:C0936150

object_name: Malaria, antepartum


subject: UMLS:C0936150

object_name: Gestational age and weight conditions


subject: UMLS:C0936150

object_name: Malaria in mother complicating childbirth


subject: UMLS:C0936150

object_name: abortion


subject: UMLS:C0936150

object_name: Fetal Death


subject: CHEBI:73770

subject_name: Ala-Leu


subject: CHEBI:73770


subject: CHEBI:73770


subject: CHEBI:73770


subject: CHEBI:73770


subject: CHEBI:73770


subject: CHEBI:73770


subject: CHEBI:73770


subject: CHEBI:73838

subject_name: D-Ala-Leu


subject: CHEBI:73838


subject: CHEBI:73838


subject: CHEBI:73838


subject: CHEBI:73838


subject: CHEBI:73838


subject: CHEBI:73838


subject: CHEBI:73838


subject: CHEBI:30136

subject_name: Aluminium


subject: CHEBI:30136


subject: CHEBI:30136


subject: CHEBI:30136


subject: CHEBI:30136


subject: CHEBI:30136


subject: CHEBI:30136


subject: CHEBI:30136


subject: CHEBI:28984

subject_name: aluminium atom


subject: CHEBI:28984


subject: CHEBI:28984


subject: CHEBI:28984


subject: CHEBI:28984


subject: CHEBI:28984


subject: CHEBI:28984


subject: CHEBI:28984


subject: CHEBI:5062

subject_name: Finasteride

object_name: Frontal balding


subject: CHEMBL.COMPOUND:CHEMBL4594569

subject_name: AMLITELIMAB

object_name: alopecia areata


subject: CHEMBL.COMPOUND:CHEMBL4594569

object_name: alopecia


subject: UMLS:C5555444

subject_name: Amlitelimab


subject: UMLS:C5555444


subject: CHEBI:8768

subject_name: Rabeprazole

object_name: tubular adenocarcinoma


subject: CHEBI:47426

subject_name: Furosemide

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:47426

object_name: secondary hyperparathyroidism


subject: CHEBI:5778

subject_name: Hydrochlorothiazide


subject: CHEBI:5778


subject: UNII:K9NXW456E2

subject_name: ispaghula seed

object_name: Constipation


subject: UNII:K9NXW456E2

object_name: Constipation, CTCAE


subject: UMLS:C0282328

subject_name: ispaghula extract


subject: UMLS:C0282328


subject: UMLS:C0910794

object_name: lung disorder


subject: PR:000013574

subject_name: sulfhydryl oxidase 1

object_name: Malignant neoplasm of stomach stage IV


subject: CHEBI:86319

subject_name: 25-hydroxyvitamin D2

object_name: end stage renal failure


subject: CHEBI:86319

object_name: Chronic uremia


subject: CHEBI:17933

subject_name: Calcifediol


subject: PUBCHEM.COMPOUND:21183636

subject_name: Atosiban

object_name: infertility


subject: UMLS:C0078129


subject: UMLS:C4724944

object_name: Cigarette Smoking-Related Carcinoma


subject: CHEBI:84500

subject_name: varenicline


subject: CHEBI:47808

subject_name: Sulforaphane

object_name: Stage 3 chronic kidney disease


subject: CHEBI:47808

object_name: Stage 4 chronic kidney disease


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: Solid Neoplasm


subject: CHEBI:28680

subject_name: Cytarabine


subject: PUBCHEM.COMPOUND:76022323

subject_name: Idasanutlin

object_name: childhood acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:76022323

object_name: acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:76022323

object_name: adult acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:76022323

object_name: adult acute myeloid leukemia


subject: PUBCHEM.COMPOUND:76022323

object_name: childhood acute myeloid leukemia


subject: PUBCHEM.COMPOUND:76022323

object_name: Childhood Neuroblastoma


subject: PUBCHEM.COMPOUND:76022323

object_name: neuroblastoma


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632

object_name: acute myeloid leukemia


subject: CHEBI:133021

subject_name: Venetoclax


subject: MESH:C530986

subject_name: Glucerna

object_name: hypoglycemia


subject: MESH:C530986

object_name: Blood glucose below reference range (finding)


subject: MESH:C530986

object_name: Hypoglycemia, CTCAE


subject: MESH:C530986

object_name: Malnutrition related diabetes mellitus


subject: PUBCHEM.COMPOUND:3962

object_name: fragile X syndrome


subject: CHEBI:40303

subject_name: Lovastatin


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline


subject: CHEBI:4315

subject_name: Danazol

object_name: diabetic macular edema


subject: UMLS:C0002525

subject_name: Amino Acids, Essential

object_name: lumbar spinal stenosis


subject: UMLS:C0002525

object_name: spinal stenosis


subject: UMLS:C4053668

object_name: neoplasm


subject: UNII:3K5H4TX2KP

subject_name: COBOLIMAB


subject: UMLS:C4287698

subject_name: Cobolimab


subject: GTOPDB:11649

subject_name: feladilimab


subject: UNII:OUP4QB2A3R

subject_name: FELADILIMAB


subject: UMLS:C4743433

subject_name: onabotulinum toxin A

object_name: pelvic pain on the left


subject: UMLS:C4743433

object_name: pelvic pain occurs with urination


subject: UMLS:C4743433

object_name: pelvic pain occurs with bowel movement


subject: UMLS:C4743433

object_name: pelvic pain decreasing in severity


subject: UMLS:C4743433

object_name: Pelvic pain female


subject: UMLS:C4743433

object_name: pelvic pain increasing in severity


subject: UMLS:C4743433

object_name: male pelvic pain


subject: UMLS:C4743433

object_name: pelvic pain to the rear


subject: UMLS:C4743433

object_name: pelvic pain on the right


subject: UMLS:C4743433

object_name: pelvic pain decreasing in frequency


subject: UMLS:C4743433

object_name: Pelvic pain


subject: UMLS:C4743433

object_name: Pelvic Pain, CTCAE 5.0


subject: UMLS:C4743433

object_name: pelvic pain causes awakening at night


subject: UMLS:C4743433

object_name: pelvic pain increasing in frequency


subject: UMLS:C4743433

object_name: pelvic pain occurs with intercourse


subject: UMLS:C4743433

object_name: pelvic pain in front


subject: CHEBI:187893

subject_name: Baclofen

object_name: Muscle spasm


subject: CHEBI:187893

object_name: Hyperkinesia


subject: CHEBI:187893

object_name: Cirrhosis


subject: CHEBI:187893

object_name: liver cirrhosis


subject: DRUGBANK:DB10533

subject_name: Grape

object_name: Oral Mucositis


subject: DRUGBANK:DB10533

object_name: stomatitis


subject: DRUGBANK:DB10533

object_name: oral mucositis


subject: DRUGBANK:DB10533

object_name: Neck Carcinoma


subject: DRUGBANK:DB10533

object_name: head and neck neoplasm


subject: DRUGBANK:DB10533

object_name: head and neck cancer


subject: UNII:90ZX3Q3FR7

subject_name: Risankizumab

object_name: psoriatic arthritis


subject: UMLS:C4078397


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: placental retention


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Salivary Gland High Grade Carcinoma


subject: UMLS:C2346820


subject: CHEBI:4672

subject_name: Docetaxel


subject: PUBCHEM.COMPOUND:91976568

subject_name: Teduglutide

object_name: Postoperative fistula


subject: UMLS:C1098514


subject: CHEBI:31717

subject_name: Ioversol

object_name: acute myeloid leukemia


subject: CHEBI:31717

object_name: Myelodysplasia


subject: CHEBI:31717

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:31717

object_name: plasma cell myeloma


subject: CHEBI:38940

subject_name: Sunitinib

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:38940

object_name: medullary thyroid gland carcinoma


subject: CHEBI:38940

object_name: stage IVA papillary thyroid cancer


subject: CHEBI:38940

object_name: stage IVB papillary thyroid cancer


subject: CHEBI:38940

object_name: stage IVC papillary thyroid cancer


subject: CHEBI:38940

object_name: stage IVB follicular thyroid cancer


subject: CHEBI:38940

object_name: stage IVA follicular thyroid cancer


subject: CHEBI:38940

object_name: stage IVC follicular thyroid cancer


subject: CHEBI:41500

subject_name: Phenylbutyrates

object_name: medium chain acyl-CoA dehydrogenase deficiency


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: cerebral palsy


subject: CHEMBL.COMPOUND:CHEMBL2108391

subject_name: HONEY

object_name: post operative nausea and vomiting


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: type 1 diabetes mellitus 1


subject: CHEBI:201431

object_name: type 1 diabetes mellitus


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: UMLS:C1314420

subject_name: INJECTION, RASBURICASE, 0.5 MG ADMINISTERED

object_name: graft versus host disease


subject: UMLS:C1314420


subject: UMLS:C1314420

object_name: myeloproliferative neoplasm


subject: UMLS:C1314420

object_name: Myelodysplasia


subject: UNII:08GY9K1EUO

subject_name: Rasburicase


subject: UNII:08GY9K1EUO


subject: UNII:08GY9K1EUO


subject: UNII:08GY9K1EUO


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: PUBCHEM.COMPOUND:135659064

subject_name: Folfox

object_name: carcinoma of esophagus


subject: PUBCHEM.COMPOUND:135659064

object_name: esophageal cancer


subject: PUBCHEM.COMPOUND:135659064

object_name: Childhood Esophageal Carcinoma


subject: PUBCHEM.COMPOUND:135659064

object_name: neoplasm of esophagus


subject: CHEBI:32599

object_name: COPD, severe early onset


subject: CHEBI:32599

object_name: chronic obstructive pulmonary disease


subject: UMLS:C5667079

subject_name: Anti-EGFR/anti-HER3 Antibody-drug Conjugate BL-B01D1

object_name: renal carcinoma


subject: UMLS:C5667079

object_name: kidney cancer


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: Sicca Syndrome


subject: CHEBI:61057

object_name: xerophthalmia


subject: CHEBI:61057

object_name: dry eye syndrome


subject: CHEBI:61057

object_name: Dry Eye Syndrome, CTCAE


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: MESH:C000730996

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: MESH:C000730996

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UNII:1IJV77EI07

subject_name: Tepotinib

object_name: MET Exon 14 Mutation


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: Arrhythmia


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:28689

subject_name: Prasterone


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form

object_name: thyroid disease


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Anticoagulant adverse reaction


subject: CHEBI:5494

subject_name: ritropirronium bromide

object_name: Fever


subject: CHEBI:5494

object_name: Fever symptoms (finding)


subject: CHEBI:5494

object_name: Fever, CTCAE


subject: CHEBI:94449

subject_name: Glycopyrronium


subject: CHEBI:94449


subject: CHEBI:94449


subject: GTOPDB:9778

subject_name: cusatuzumab

object_name: Myelodysplasia


subject: GTOPDB:9778

object_name: chronic myelomonocytic leukemia


subject: CHEMBL.COMPOUND:CHEMBL4297891

subject_name: CUSATUZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297891


subject: UMLS:C3827163

subject_name: Cusatuzumab


subject: CHEBI:61057

object_name: Organ transplant failure or rejection


subject: CHEBI:61057

object_name: Brainstem death


subject: CHEBI:61057

object_name: Brain Death


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: UMLS:C0338133

subject_name: Gemzar

object_name: pancreatic adenocarcinoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Angioimmunoblastic T-cell lymphoma refractory


subject: CHEBI:4026

object_name: Angioimmunoblastic T-cell lymphoma recurrent


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:135918

subject_name: Tucidinostat


subject: CHEBI:135918


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Locally Advanced Lung Non-Small Cell Carcinoma


subject: CHEBI:231679

object_name: Locally Advanced Ureter Urothelial Carcinoma


subject: CHEBI:231679

object_name: Locally Advanced Bladder Urothelial Carcinoma


subject: CHEBI:231679

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: CHEBI:231679

object_name: Locally Advanced Urethral Urothelial Carcinoma


subject: CHEBI:231679

object_name: Locally Advanced Bladder Carcinoma


subject: CHEBI:231679

object_name: Urothelial carcinoma ureter metastatic


subject: CHEBI:231679

object_name: Metastatic Bladder Urothelial Carcinoma


subject: CHEBI:231679

object_name: Locally Advanced Renal Pelvis Urothelial Carcinoma


subject: CHEBI:231679

object_name: Metastatic Urethral Urothelial Carcinoma


subject: CHEBI:231679

object_name: Locally Advanced Renal Pelvis Carcinoma


subject: CHEBI:231679

object_name: Stage IV Lung Cancer AJCC v6


subject: CHEBI:231679

object_name: Metastatic Renal Pelvis Urothelial Carcinoma


subject: CHEBI:231679

object_name: Stage III Lung Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IIIB Lung Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IIIC Lung Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IIIA Lung Cancer AJCC v8


subject: CHEBI:231679

object_name: Metastatic Urethral Carcinoma


subject: CHEBI:231679

object_name: Stage IV Urethral Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage III Urethral Cancer AJCC v8


subject: CHEBI:231679

object_name: Bladder cancer stage IV


subject: CHEBI:231679

object_name: Stage III Ureter Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IV Ureter Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage III Bladder Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IV Bladder Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IIIA Bladder Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IIIB Bladder Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage III Renal Pelvis Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IV Renal Pelvis Cancer AJCC v8


subject: CHEBI:231679

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:231679

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: CHEBI:231679

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: CHEBI:231679

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: CHEBI:231679

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Locally Advanced Lung Non-Small Cell Carcinoma


subject: CHEBI:231614

object_name: Locally Advanced Bladder Carcinoma


subject: CHEBI:231614

object_name: Locally Advanced Renal Pelvis Carcinoma


subject: CHEBI:231614

object_name: Stage IV Lung Cancer AJCC v6


subject: CHEBI:231614

object_name: Metastatic Urethral Carcinoma


subject: CHEBI:231614

object_name: Bladder cancer stage IV


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: UNII:I031V2H011

object_name: Locally Advanced Ureter Urothelial Carcinoma


subject: UNII:I031V2H011

object_name: Locally Advanced Bladder Urothelial Carcinoma


subject: UNII:I031V2H011

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: UNII:I031V2H011

object_name: Locally Advanced Urethral Urothelial Carcinoma


subject: UNII:I031V2H011


subject: UNII:I031V2H011

object_name: Urothelial carcinoma ureter metastatic


subject: UNII:I031V2H011

object_name: Metastatic Bladder Urothelial Carcinoma


subject: UNII:I031V2H011

object_name: Locally Advanced Renal Pelvis Urothelial Carcinoma


subject: UNII:I031V2H011

object_name: Metastatic Urethral Urothelial Carcinoma


subject: UNII:I031V2H011


subject: UNII:I031V2H011


subject: UNII:I031V2H011

object_name: Metastatic Renal Pelvis Urothelial Carcinoma


subject: UNII:I031V2H011

object_name: Stage III Lung Cancer AJCC v8


subject: UNII:I031V2H011

object_name: Stage IVA Lung Cancer AJCC v8


subject: UNII:I031V2H011

object_name: Stage IVB Lung Cancer AJCC v8


subject: UNII:I031V2H011

object_name: Stage IIIB Lung Cancer AJCC v8


subject: UNII:I031V2H011

object_name: Stage IIIC Lung Cancer AJCC v8


subject: UNII:I031V2H011

object_name: Stage IIIA Lung Cancer AJCC v8


subject: UNII:I031V2H011

object_name: Metastatic Urethral Carcinoma


subject: UNII:I031V2H011

object_name: Stage IV Urethral Cancer AJCC v8


subject: UNII:I031V2H011

object_name: Stage III Urethral Cancer AJCC v8


subject: UNII:I031V2H011

object_name: Bladder cancer stage IV


subject: UNII:I031V2H011

object_name: Stage III Ureter Cancer AJCC v8


subject: UNII:I031V2H011

object_name: Stage IV Ureter Cancer AJCC v8


subject: UNII:I031V2H011

object_name: Stage III Bladder Cancer AJCC v8


subject: UNII:I031V2H011

object_name: Stage IV Bladder Cancer AJCC v8


subject: UNII:I031V2H011

object_name: Stage IIIA Bladder Cancer AJCC v8


subject: UNII:I031V2H011

object_name: Stage IIIB Bladder Cancer AJCC v8


subject: UNII:I031V2H011

object_name: Stage III Renal Pelvis Cancer AJCC v8


subject: UNII:I031V2H011

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: UNII:I031V2H011

object_name: Stage IV Renal Pelvis Cancer AJCC v8


subject: UNII:I031V2H011

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: UNII:I031V2H011

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: UNII:I031V2H011

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: UNII:I031V2H011

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: UNII:I031V2H011

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: UNII:I031V2H011

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: UNII:I031V2H011

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: UNII:I031V2H011

object_name: Malignant Solid Neoplasm


subject: UMLS:C4309933

object_name: rheumatoid arthritis


subject: UMLS:C4309933

object_name: Inflammation


subject: CHEBI:9150

subject_name: Simvastatin


subject: MESH:C557508

subject_name: SCYX 7158

object_name: trypanosomiasis


subject: MESH:C557508

object_name: human African trypanosomiasis


subject: MESH:C557508

object_name: protozoa infectious disease


subject: MESH:C557508

object_name: parasitic infectious disease


subject: CHEBI:17154

subject_name: Nicotinamide

object_name: keratinocyte carcinoma


subject: CHEBI:17154

object_name: skin carcinoma


subject: CHEBI:17154

object_name: basal cell carcinoma


subject: CHEBI:17154

object_name: skin basal cell carcinoma


subject: CHEBI:17154

object_name: squamous cell carcinoma


subject: MESH:C575982

subject_name: docosahexaenoic acid monoacylglyceride

object_name: cystic fibrosis


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Acute migraine


subject: CHEBI:107736

subject_name: Metoclopramide


subject: CHEBI:60654

subject_name: valproate


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Depressed mood


subject: CHEBI:3160

object_name: Cancer patients and suicide and depression


subject: CHEBI:3160

object_name: Depressed - symptom


subject: CHEBI:3160

object_name: Depression, CTCAE


subject: UMLS:C3489693

object_name: endogenous depression


subject: UMLS:C3489693

object_name: major depressive disorder


subject: CHEBI:196955

subject_name: Atogepant

object_name: Migraine with or without aura


subject: UMLS:C1172252

subject_name: substance P-saporin

object_name: Pain, Intractable


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Postoperative wound hemorrhage


subject: CHEBI:180651

subject_name: Eliprodil

object_name: Parkinson disease


subject: CHEBI:180651

object_name: movement disorder


subject: CHEBI:76609

subject_name: Aprocitentan

object_name: Hepatic impairment


subject: PUBCHEM.COMPOUND:67068474

subject_name: Anagliptin

object_name: low density lipoprotein cholesterol measurement


subject: PUBCHEM.COMPOUND:67068474

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:67068474

object_name: Glycosylated hemoglobin level


subject: PUBCHEM.COMPOUND:67068474

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin


subject: PUBCHEM.COMPOUND:11306691


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:40237


subject: UMLS:C5554588

subject_name: CD3-activating CD19 Bi-specific Antibody A-319

object_name: EXCESS LMW-DNA


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Vitreous Hemorrhage, CTCAE 5.0


subject: UNII:2S9ZZM9Q9V

object_name: Vitreous Hemorrhage, CTCAE 3.0


subject: UNII:2S9ZZM9Q9V

object_name: Vitreous hemorrhage


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: PUBCHEM.COMPOUND:1805

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: PUBCHEM.COMPOUND:1805

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: PUBCHEM.COMPOUND:1805

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: PUBCHEM.COMPOUND:1805

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: PUBCHEM.COMPOUND:1805

object_name: Adult Acute Myelomonocytic Leukemia


subject: PUBCHEM.COMPOUND:1805

object_name: Adult Pure Erythroid Leukemia


subject: PUBCHEM.COMPOUND:1805

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: PUBCHEM.COMPOUND:1805

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: PUBCHEM.COMPOUND:1805

object_name: Adult Acute Monoblastic Leukemia


subject: PUBCHEM.COMPOUND:1805

object_name: acute megakaryoblastic leukemia in adult


subject: PUBCHEM.COMPOUND:1805

object_name: Adult Erythroleukemia


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: UNII:8GZG754X6M

subject_name: Gemtuzumab


subject: UNII:8GZG754X6M


subject: UNII:8GZG754X6M


subject: UNII:8GZG754X6M

object_name: recurrent adult acute myeloid leukemia


subject: UNII:8GZG754X6M


subject: UNII:8GZG754X6M


subject: UNII:8GZG754X6M


subject: UNII:8GZG754X6M


subject: UNII:8GZG754X6M


subject: UNII:8GZG754X6M

object_name: adult acute monocytic leukemia


subject: UNII:8GZG754X6M


subject: UNII:8GZG754X6M


subject: UNII:8GZG754X6M


subject: UNII:8GZG754X6M


subject: UMLS:C0677800

subject_name: CMA 676


subject: UMLS:C0677800


subject: UMLS:C0677800


subject: UMLS:C0677800


subject: UMLS:C0677800


subject: UMLS:C0677800


subject: UMLS:C0677800


subject: UMLS:C0677800


subject: UMLS:C0677800


subject: UMLS:C0677800


subject: UMLS:C0677800


subject: UMLS:C0677800


subject: UMLS:C0677800


subject: UMLS:C0677800


subject: CHEBI:45716

subject_name: Vorinostat


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: PUBCHEM.COMPOUND:66586232

object_name: oral candidiasis


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: tumor suppressor gene on chromosome 11


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:146178

subject_name: RACEMETHORPHAN

object_name: proteinuria


subject: CHEBI:146178

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:146178

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:146178

object_name: Proteinuria, CTCAE 5.0


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:146176


subject: CHEBI:146176


subject: CHEBI:146176


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:4470


subject: CHEBI:4470


subject: CHEBI:4470


subject: CHEBI:9144

subject_name: Silibinin


subject: CHEBI:9144


subject: CHEBI:9144


subject: CHEBI:9144


subject: CHEBI:125451

subject_name: silymarin


subject: CHEBI:125451


subject: CHEBI:125451


subject: CHEBI:125451


subject: GTOPDB:8415

subject_name: tanezumab

object_name: chronic pancreatitis


subject: UNII:EQL0E9GCX1


subject: UMLS:C2346819


subject: CHEMBL.COMPOUND:CHEMBL2108947

subject_name: COLD CREAM

object_name: Diaper Rash


subject: UMLS:C0302231

subject_name: Cold cream


subject: UMLS:C0975888

subject_name: Cold Cream Topical Cream


subject: DRUGBANK:DB11286

subject_name: Colloidal oatmeal


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Demonstrates adequate pain control


subject: UMLS:C5706513

subject_name: Stapokibart

object_name: Hay fever


subject: CHEBI:55379

subject_name: camphorsulfonic acid

object_name: Cockayne syndrome type 1


subject: CHEBI:55379

object_name: central sleep apnea syndrome


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: PR:000007170

subject_name: DNA excision repair protein ERCC-8


subject: PR:000007170


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin


subject: UMLS:C0003442


subject: CHEMBL.COMPOUND:CHEMBL2108059

subject_name: VELAFERMIN

object_name: Oral Mucositis


subject: CHEMBL.COMPOUND:CHEMBL2108059

object_name: stomatitis


subject: CHEMBL.COMPOUND:CHEMBL2108059

object_name: oral mucositis


subject: UMLS:C1451237


subject: UMLS:C1451237


subject: UMLS:C1451237


subject: UMLS:C4764292

object_name: plasma cell myeloma


subject: CHEBI:93274

subject_name: Fluvoxamine

object_name: pervasive developmental disorder


subject: CHEBI:93274

object_name: autism


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: systemic sclerosis


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:M17ILL71MC

subject_name: Efatutazone

object_name: adult liposarcoma


subject: UNII:M17ILL71MC

object_name: liposarcoma


subject: UNII:M17ILL71MC

object_name: pediatric liposarcoma


subject: UNII:C857R7G2U6

subject_name: SODIUM PENTABORATE PENTAHYDRATE

object_name: Alzheimer disease type 1


subject: UNII:C857R7G2U6

object_name: Alzheimer disease


subject: UMLS:C5848978

subject_name: Sodium Pentaborate Pentahydrate


subject: UMLS:C5848978


subject: UNII:102MC1467J

object_name: hepatitis C


subject: CHEBI:6909

subject_name: Metronidazole

object_name: Crohn disease


subject: CHEBI:35176

subject_name: Zinc sulfate

object_name: Appetite Disorders


subject: UMLS:C4045914

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:11360300

subject_name: TRELAGLIPTIN


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: UNII:2S9ZZM9Q9V

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: UNII:2S9ZZM9Q9V

object_name: stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Metabolic Problems


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:4466

object_name: Airway complication of anaesthesia


subject: UNII:7N8K34P2XH


subject: UMLS:C0360094

subject_name: iv lidocaine


subject: PUBCHEM.COMPOUND:57505028

subject_name: Suvorexant

object_name: multiple sclerosis


subject: PUBCHEM.COMPOUND:57505028

object_name: Fatigue, CTCAE 5.0


subject: PUBCHEM.COMPOUND:57505028

object_name: Fatigue


subject: PUBCHEM.COMPOUND:164532637

object_name: Liver Fibrosis


subject: PUBCHEM.COMPOUND:164532637

object_name: liver cirrhosis


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug

object_name: carpal tunnel syndrome


subject: UMLS:C0003211

subject_name: Anti-Inflammatory Agents, Non-Steroidal


subject: UMLS:C0358845

subject_name: Analgesics and non-steroidal anti-inflammatory drugs


subject: CHEBI:7726

subject_name: octreotide

object_name: Hemorrhagic Shock


subject: CHEBI:7726

object_name: Bleeding varices


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Adverse effects of medical drugs


subject: UNII:NWR3BEB8PA

subject_name: Iferanserin

object_name: hemorrhoid


subject: UNII:NWR3BEB8PA

object_name: Hemorrhoids, CTCAE 3.0


subject: UNII:NWR3BEB8PA

object_name: Hemorrhoids, CTCAE 5.0


subject: CHEBI:133021

subject_name: Venetoclax

object_name: High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: CHEBI:133021

object_name: high-grade B-cell lymphoma double-hit/triple-hit


subject: CHEBI:133021

object_name: Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present


subject: CHEBI:133021

object_name: Double-Expressor Lymphoma


subject: CHEBI:133021

object_name: Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly


subject: CHEBI:133021

object_name: Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma


subject: CHEBI:2676

subject_name: Amoxicillin

object_name: thrombocytopenia due to immune destruction


subject: CHEBI:2676

object_name: autoimmune thrombocytopenic purpura


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: autoimmune thrombocytopenia


subject: CHEBI:73604


subject: CHEBI:73604


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Adult Hodgkin Lymphoma


subject: GTOPDB:9592

object_name: Childhood Hodgkin Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: relapsing polychondritis


subject: CHEBI:2948

subject_name: Azathioprine


subject: UNII:B72HH48FLU

subject_name: Infliximab


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: UniProtKB:P47802

subject_name: MTX1_MOUSE Metaxin-1 (sprot)


subject: PR:000010755


subject: CHEBI:231601

subject_name: trastuzumab

object_name: ductal breast carcinoma in situ


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UNII:V4E0A9M44Q

subject_name: Etavopivat

object_name: liver disorder


subject: CHEBI:231702

subject_name: Tirbanibulin

object_name: actinic keratosis


subject: UMLS:C3884609

object_name: hypoalphalipoproteinemia, primary, 1


subject: UMLS:C3884609

object_name: Tangier disease


subject: UMLS:C3884609

object_name: Apolipoprotein A-I deficiency


subject: UMLS:C4087059

subject_name: NPC-12G Gel

object_name: tuberous sclerosis


subject: UMLS:C4087059

object_name: situs inversus


subject: UMLS:C4087059

object_name: Angiofibromas


subject: UMLS:C4087059

object_name: Hypomelanotic macule


subject: UMLS:C4087059

object_name: Dental Plaque


subject: UMLS:C4087059

object_name: Skin plaque


subject: UMLS:C4087059

object_name: Senile plaques


subject: UMLS:C4087059

object_name: Plaque (lesion)


subject: UNII:2N4O9L084N

subject_name: Nabilone

object_name: peripheral nervous system disorder


subject: UNII:2N4O9L084N

object_name: neuropathy


subject: CHEBI:91951

object_name: Stage III Uterine Corpus Cancer


subject: CHEBI:91951

object_name: Stage IV Uterine Corpus Cancer


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: PUBCHEM.COMPOUND:17756771


subject: UMLS:C1518041

subject_name: Luteinizing Hormone-releasing Hormone Agonist

object_name: ovarian hyperstimulation syndrome


subject: DRUGBANK:DB17293

subject_name: Hiltonol

object_name: Disseminated Malignant Neoplasm


subject: DRUGBANK:DB17293

object_name: Embolism, Tumor


subject: DRUGBANK:DB17293

object_name: Neoplasm Metastasis


subject: DRUGBANK:DB17293

object_name: Stomach cancer


subject: DRUGBANK:DB17293

object_name: gastric cancer


subject: DRUGBANK:DB17293

object_name: liver cancer


subject: DRUGBANK:DB17293

object_name: liver neoplasm


subject: DRUGBANK:DB17293

object_name: Adult Liver Carcinoma


subject: DRUGBANK:DB17293

object_name: Childhood Breast Carcinoma


subject: DRUGBANK:DB17293

object_name: breast carcinoma


subject: DRUGBANK:DB17293

object_name: breast cancer


subject: DRUGBANK:DB17293

object_name: pancreatic neoplasm


subject: DRUGBANK:DB17293

object_name: exocrine pancreatic carcinoma


subject: DRUGBANK:DB17293

object_name: malignant pancreatic neoplasm


subject: DRUGBANK:DB17293

object_name: colorectal cancer


subject: DRUGBANK:DB17293

object_name: colorectal carcinoma


subject: DRUGBANK:DB17293

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: DRUGBANK:DB17293

object_name: ovarian cancer


subject: DRUGBANK:DB17293

object_name: ovarian neoplasm


subject: DRUGBANK:DB17293

object_name: skin melanoma


subject: UNII:7KYP9TKT70

subject_name: poly ICLC

object_name: Disseminated Malignant Neoplasm


subject: UNII:7KYP9TKT70

object_name: Embolism, Tumor


subject: UNII:7KYP9TKT70

object_name: Neoplasm Metastasis


subject: UNII:7KYP9TKT70

object_name: Stomach cancer


subject: UNII:7KYP9TKT70

object_name: gastric cancer


subject: UNII:7KYP9TKT70

object_name: liver cancer


subject: UNII:7KYP9TKT70

object_name: liver neoplasm


subject: UNII:7KYP9TKT70

object_name: Adult Liver Carcinoma


subject: UNII:7KYP9TKT70

object_name: Childhood Breast Carcinoma


subject: UNII:7KYP9TKT70

object_name: breast carcinoma


subject: UNII:7KYP9TKT70

object_name: breast cancer


subject: UNII:7KYP9TKT70

object_name: pancreatic neoplasm


subject: UNII:7KYP9TKT70

object_name: exocrine pancreatic carcinoma


subject: UNII:7KYP9TKT70

object_name: malignant pancreatic neoplasm


subject: UNII:7KYP9TKT70

object_name: colorectal cancer


subject: UNII:7KYP9TKT70

object_name: colorectal carcinoma


subject: UNII:7KYP9TKT70

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:7KYP9TKT70

object_name: ovarian cancer


subject: UNII:7KYP9TKT70

object_name: ovarian neoplasm


subject: UNII:7KYP9TKT70

object_name: skin melanoma


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: Refractory Childhood Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:3368

object_name: myelodysplastic syndrome with excess blasts-1


subject: PUBCHEM.COMPOUND:3368

object_name: myelodysplastic syndrome with excess blasts-2


subject: PUBCHEM.COMPOUND:3368

object_name: Refractory Adult Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:3368

object_name: acute leukemia of ambiguous lineage


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:93775


subject: CHEBI:93775

object_name: myelodysplastic syndrome with excess blasts


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775

object_name: Infant Acute Undifferentiated Leukemia


subject: CHEBI:93775

object_name: acute undifferentiated leukemia


subject: CHEBI:93775

object_name: Infant Acute Biphenotypic Leukemia


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:9570

subject_name: Thiotepa

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:9570

object_name: Blast Phase


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570

object_name: acute biphenotypic leukemia


subject: CHEBI:9570


subject: CHEBI:145371

subject_name: Binimetinib

object_name: Melanoma of Unknown Primary


subject: CHEBI:145371

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: CHEBI:145371

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: CHEBI:145371

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: CHEBI:145371

object_name: metastatic malignant neoplasm in the lymph nodes


subject: UNII:8L7891MRB6

subject_name: Encorafenib


subject: UNII:8L7891MRB6

object_name: Melanoma recurrent


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: GTOPDB:12990

subject_name: sintilimab

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: CHEBI:64073

object_name: hypoglycemia


subject: CHEBI:64073

object_name: Blood glucose below reference range (finding)


subject: CHEBI:64073

object_name: Hypoglycemia, CTCAE


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: UNII:9P1872D4OL


subject: UNII:9P1872D4OL


subject: UMLS:C1831616

object_name: prostate carcinoma


subject: UMLS:C1831616

object_name: prostate cancer


subject: CHEBI:75934

subject_name: Vadimezan


subject: CHEBI:75934


subject: CHEBI:125400

subject_name: actinomycin D

object_name: Non-Metastatic Gestational Trophoblastic Tumor


subject: CHEBI:125400

object_name: Good Prognosis Metastatic Gestational Trophoblastic Tumor


subject: CHEBI:125400

object_name: uterine corpus choriocarcinoma


subject: CHEBI:125400

object_name: hydatidiform mole


subject: CHEBI:125400

object_name: hydatidiform mole, recurrent, 1


subject: CHEBI:27666

subject_name: Dactinomycin


subject: CHEBI:27666


subject: CHEBI:27666


subject: CHEBI:27666


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: BK virus infection


subject: CHEBI:6402

subject_name: Leflunomide


subject: CHEBI:6402

object_name: Infection of transplanted kidney


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: colorectal cancer


subject: CHEBI:201431

object_name: colorectal carcinoma


subject: CHEBI:201431

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:15365

subject_name: Aspirin

object_name: adhesions of uterus


subject: CHEBI:72313

subject_name: pasireotide aspartate

object_name: dumping syndrome


subject: UMLS:C1136845


subject: UMLS:C5205553

subject_name: Anti-CD52 Monoclonal Antibody ALLO-647

object_name: Relapsed/refractory multiple myeloma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: UMLS:C4305641

object_name: stroke disorder


subject: GTOPDB:4934

subject_name: G-CSF


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:50692

subject_name: Mifepristone

object_name: invasive breast carcinoma


subject: CHEBI:50692

object_name: ductal breast carcinoma in situ


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: biliary atresia


subject: CHEBI:29947

subject_name: glycine residue

object_name: schizophrenia


subject: CHEBI:15428

subject_name: Glycine


subject: PR:000003493

subject_name: granzyme F

object_name: Anaplastic astrocytoma of brain


subject: PR:000003493

object_name: brain glioblastoma


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: cardiomyopathy


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:6432

subject_name: Levamisole

object_name: epilepsy


subject: CHEBI:7496

subject_name: Nelfinavir

object_name: Kaposi Sarcoma


subject: UMLS:C3898587

subject_name: Liposomal Mitoxantrone Hydrochloride

object_name: Childhood Solid Neoplasm


subject: UMLS:C0935692

object_name: neuroendocrine neoplasm


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: soft tissue sarcoma


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: UMLS:C1174389

object_name: sarcoma


subject: UMLS:C1174389


subject: CHEBI:14648

subject_name: NMN(+)

object_name: Injury of liver


subject: CHEBI:14648

object_name: Fatty Liver


subject: CHEBI:14648

object_name: Binge Drinking


subject: CHEBI:14648

object_name: Binge drinking


subject: CHEBI:28918

subject_name: Epinephrine

object_name: cervical intraepithelial neoplasia


subject: CHEBI:28918

object_name: dysplasia of cervix


subject: CHEBI:194548

subject_name: Racepinephrine


subject: CHEBI:194548


subject: CHEBI:3215

subject_name: Bupivacaine


subject: CHEBI:3215


subject: UMLS:C3827032

subject_name: Catequentinib Hydrochloride

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C3827032

object_name: clear cell renal carcinoma


subject: UMLS:C3827032

object_name: renal cell adenocarcinoma


subject: UMLS:C3827032

object_name: renal cell carcinoma


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: skin disease caused by bacterial infection


subject: UNII:6GNT3Y5LMF

object_name: cellulitis


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:63598


subject: CHEBI:49375

subject_name: Dasatinib

object_name: Primary human immunodeficiency virus infection


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: adult dermatomyositis


subject: UNII:7D0YB67S97

object_name: dermatomyositis


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: CHEBI:3070

subject_name: Bestatin

object_name: pulmonary hypertension, primary, 1


subject: CHEBI:3070

object_name: pulmonary hypertension


subject: CHEBI:3070

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:3070

object_name: pulmonary arterial hypertension


subject: UNII:I0J33N5627

subject_name: Ubenimex


subject: UNII:I0J33N5627


subject: UNII:I0J33N5627


subject: UNII:I0J33N5627


subject: UMLS:C5706513

subject_name: Stapokibart

object_name: atopic eczema


subject: CHEBI:8988

object_name: Childhood Desmoplastic Small Round Cell Tumor


subject: CHEBI:8988

object_name: desmoplastic small round cell tumor


subject: CHEBI:8988

object_name: Adult Desmoplastic Small Round Cell Tumor


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: UNII:820NH671E6

subject_name: Prexasertib

object_name: Adult Rhabdomyosarcoma


subject: UNII:820NH671E6

object_name: rhabdomyosarcoma


subject: UNII:820NH671E6

object_name: Childhood Rhabdomyosarcoma


subject: UNII:820NH671E6

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UNII:820NH671E6


subject: UNII:820NH671E6


subject: UNII:820NH671E6


subject: PUBCHEM.COMPOUND:160883

subject_name: Butylscopolamine

object_name: Birthing Labor


subject: CHEBI:26710

subject_name: Sodium chloride


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Secondary malignant neoplasm of lung


subject: UNII:PQX0D8J21J

object_name: Recurrent lung cancer


subject: UNII:PQX0D8J21J

object_name: Recurrent Unspecified Lung Carcinoma


subject: UNII:PQX0D8J21J

object_name: BRAF mutation-related tumors


subject: UNII:PQX0D8J21J

object_name: Solid carcinoma


subject: UNII:PQX0D8J21J

object_name: KRAS mutation-related tumors


subject: UNII:PQX0D8J21J

object_name: BRAF V600 Protein Variation


subject: UNII:PQX0D8J21J

object_name: N-ras gene mutation


subject: UNII:PQX0D8J21J

object_name: BRAF gene mutation


subject: UNII:PQX0D8J21J

object_name: thyroid gland carcinoma


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J

object_name: thyroid tumor


subject: UNII:PQX0D8J21J

object_name: thyroid cancer


subject: UNII:PQX0D8J21J

object_name: metastatic malignant neoplasm in the brain


subject: UNII:PQX0D8J21J

object_name: Recurrent Histiocytic and Dendritic Cell Neoplasm


subject: UNII:PQX0D8J21J

object_name: histiocytic neoplasm


subject: UNII:PQX0D8J21J

object_name: histiocytic and dendritic cell neoplasm


subject: UNII:PQX0D8J21J

object_name: histiocytosis


subject: UNII:PQX0D8J21J

object_name: Histiocytic syndrome


subject: UMLS:C0879636

subject_name: IMC C225

object_name: Secondary malignant neoplasm of lung


subject: UMLS:C0879636

object_name: Recurrent lung cancer


subject: UMLS:C0879636

object_name: Recurrent Unspecified Lung Carcinoma


subject: UMLS:C0879636

object_name: BRAF mutation-related tumors


subject: UMLS:C0879636

object_name: Solid carcinoma


subject: UMLS:C0879636

object_name: KRAS mutation-related tumors


subject: UMLS:C0879636

object_name: BRAF V600 Protein Variation


subject: UMLS:C0879636

object_name: N-ras gene mutation


subject: UMLS:C0879636

object_name: BRAF gene mutation


subject: UMLS:C0879636

object_name: thyroid gland carcinoma


subject: UMLS:C0879636


subject: UMLS:C0879636

object_name: thyroid tumor


subject: UMLS:C0879636

object_name: thyroid cancer


subject: UMLS:C0879636

object_name: metastatic malignant neoplasm in the brain


subject: UMLS:C0879636

object_name: Recurrent Histiocytic and Dendritic Cell Neoplasm


subject: UMLS:C0879636

object_name: histiocytic neoplasm


subject: UMLS:C0879636

object_name: histiocytic and dendritic cell neoplasm


subject: UMLS:C0879636

object_name: histiocytosis


subject: UMLS:C0879636

object_name: Histiocytic syndrome


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Secondary malignant neoplasm of lung


subject: CHEBI:175901

object_name: Recurrent lung cancer


subject: CHEBI:175901

object_name: Recurrent Unspecified Lung Carcinoma


subject: CHEBI:175901

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: CHEBI:175901

object_name: BRAF mutation-related tumors


subject: CHEBI:175901

object_name: Solid carcinoma


subject: CHEBI:175901

object_name: KRAS mutation-related tumors


subject: CHEBI:175901

object_name: BRAF V600 Protein Variation


subject: CHEBI:175901

object_name: N-ras gene mutation


subject: CHEBI:175901

object_name: BRAF gene mutation


subject: CHEBI:175901

object_name: thyroid gland carcinoma


subject: CHEBI:175901


subject: CHEBI:175901

object_name: thyroid tumor


subject: CHEBI:175901

object_name: thyroid cancer


subject: CHEBI:175901

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:175901

object_name: Recurrent Histiocytic and Dendritic Cell Neoplasm


subject: CHEBI:175901

object_name: histiocytic neoplasm


subject: CHEBI:175901

object_name: histiocytic and dendritic cell neoplasm


subject: CHEBI:175901

object_name: histiocytosis


subject: CHEBI:175901

object_name: Histiocytic syndrome


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: Secondary malignant neoplasm of lung


subject: MESH:C520255

object_name: Recurrent lung cancer


subject: MESH:C520255

object_name: Recurrent Unspecified Lung Carcinoma


subject: MESH:C520255

object_name: Non-small cell lung cancer recurrent


subject: MESH:C520255

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: MESH:C520255

object_name: BRAF mutation-related tumors


subject: MESH:C520255

object_name: Solid carcinoma


subject: MESH:C520255

object_name: KRAS mutation-related tumors


subject: MESH:C520255

object_name: BRAF V600 Protein Variation


subject: MESH:C520255

object_name: N-ras gene mutation


subject: MESH:C520255

object_name: BRAF gene mutation


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: UNII:6A901E312A

subject_name: Panitumumab


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: UNII:6A901E312A

object_name: thyroid gland carcinoma


subject: UNII:6A901E312A


subject: UNII:6A901E312A

object_name: thyroid tumor


subject: UNII:6A901E312A

object_name: thyroid cancer


subject: UNII:6A901E312A

object_name: metastatic malignant neoplasm in the brain


subject: UNII:6A901E312A

object_name: Recurrent Histiocytic and Dendritic Cell Neoplasm


subject: UNII:6A901E312A

object_name: histiocytic neoplasm


subject: UNII:6A901E312A

object_name: histiocytic and dendritic cell neoplasm


subject: UNII:6A901E312A

object_name: histiocytosis


subject: UNII:6A901E312A

object_name: Histiocytic syndrome


subject: UNII:H1396W7D1H

subject_name: FAVEZELIMAB

object_name: renal cell carcinoma


subject: UMLS:C4684393

subject_name: Favezelimab


subject: GTOPDB:13890

subject_name: quavonlimab


subject: UNII:GG0AN49Y59

subject_name: QUAVONLIMAB


subject: UMLS:C4725918

subject_name: Quavonlimab


subject: CHEMBL.COMPOUND:CHEMBL4297785

subject_name: VIBOSTOLIMAB


subject: UMLS:C5432276

subject_name: Vibostolimab


subject: MESH:C000656706

object_name: Morton neuroma


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: meningococcal meningitis


subject: UNII:UI1U1MYH09

subject_name: Darapladib

object_name: coronary microvascular disorder


subject: UMLS:C2348075

subject_name: darapladib


subject: UMLS:C3896901

object_name: central nervous system cancer


subject: CHEBI:50249

subject_name: anticoagulant

object_name: Pathological Dilatation


subject: CHEBI:50249

object_name: coronary artery disorder


subject: CHEBI:50249

object_name: coronary atherosclerosis


subject: UMLS:C0003280

subject_name: Anticoagulants


subject: UMLS:C0003280


subject: UMLS:C0003280


subject: UMLS:C0085826

subject_name: Antiplatelet Agents


subject: GTOPDB:9596

subject_name: oleclumab

object_name: luminal B breast carcinoma


subject: UNII:5CRY01URYQ

subject_name: OLECLUMAB


subject: UMLS:C4085967

subject_name: Oleclumab


subject: UMLS:C2698138

object_name: Solid Neoplasm


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Metastatic malignant neoplasm to bone


subject: CHEBI:9168

subject_name: Sirolimus

object_name: castration-resistant prostate carcinoma


subject: CHEBI:9168


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Blood Clot


subject: CHEBI:68579

object_name: thrombosis


subject: CHEBI:68579

object_name: Thrombosis of blood vessel


subject: CHEBI:68558

subject_name: Ticagrelor


subject: CHEBI:68558


subject: CHEBI:68558


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: endocrine system disorder


subject: UMLS:C0169964

subject_name: somatropin


subject: CHEBI:25805

subject_name: oxygen atom


subject: CHEBI:15379

subject_name: Oxygen


subject: UMLS:C4763585

subject_name: Letaplimab

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C4763585

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:5118

subject_name: RACLOPRIDE

object_name: Parkinson disease


subject: UMLS:C4029782

subject_name: CFTR modulators

object_name: cystic fibrosis


subject: UMLS:C5446634

subject_name: CD19-specific Adapter Molecule SWI019

object_name: EXCESS LMW-DNA


subject: PUBCHEM.COMPOUND:3222

object_name: Heart failure with reduced ejection fraction


subject: CHEBI:4784

subject_name: Enalapril


subject: PUBCHEM.COMPOUND:54214995

subject_name: Sacubitril


subject: CHEBI:9927

subject_name: Valsartan


subject: CHEBI:681850

subject_name: Conivaptan

object_name: heart failure


subject: CHEBI:681850

object_name: Heart Failure, CTCAE


subject: UMLS:C0772411

subject_name: potato starch

object_name: hematologic disorder


subject: CHEBI:93775

subject_name: Amethopterin

object_name: juvenile idiopathic arthritis


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: UMLS:C1328149

object_name: adrenal cortex carcinoma


subject: UMLS:C1328149

object_name: adenoid cystic carcinoma


subject: CHEBI:66910

subject_name: Axitinib


subject: CHEBI:66910


subject: CHEBI:45716

subject_name: Vorinostat

object_name: diffuse midline glioma, H3 K27M-mutant


subject: CHEBI:45716

object_name: diffuse intrinsic pontine glioma


subject: CHEBI:45716

object_name: Childhood Anaplastic Oligoastrocytoma


subject: CHEBI:45716

object_name: anaplastic oligoastrocytoma


subject: CHEBI:45716

object_name: Grade III Childhood Astrocytoma


subject: CHEBI:45716

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:45716

object_name: anaplastic astrocytoma


subject: CHEBI:45716

object_name: gliosarcoma


subject: CHEBI:45716

object_name: Childhood Gliosarcoma


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: carotid stenosis


subject: UMLS:C3540778

subject_name: Glucocorticoid inhalants for obstructive airway disease

object_name: hypertension


subject: UMLS:C3540778

object_name: Hypertension, CTCAE


subject: CHEBI:24261

subject_name: glucocorticoid


subject: CHEBI:24261


subject: UMLS:C3540777

subject_name: Glucocorticoids, Systemic


subject: UMLS:C3540777


subject: CHEBI:31859

subject_name: Modafinil

object_name: multiple sclerosis


subject: CHEBI:231678

subject_name: Evofosfamide

object_name: Solid Neoplasm


subject: UMLS:C0556085

subject_name: Branched chain amino acid supplementation

object_name: Weight loss


subject: UMLS:C0556085

object_name: Weight Loss, CTCAE


subject: UMLS:C0556085

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C0556085

object_name: obesity


subject: UMLS:C0556085

object_name: Obesity, CTCAE


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: autoimmune thrombocytopenia


subject: CHEBI:6888

object_name: thrombocytopenia due to immune destruction


subject: UNII:5QS67N4551

subject_name: Conestat alfa

object_name: acute kidney failure


subject: UNII:5QS67N4551

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:27565

subject_name: Aminosalicylic acid

object_name: ulcerative colitis


subject: CHEBI:27565

object_name: inflammatory bowel disease 1


subject: UMLS:C4733690

subject_name: BTK Inhibitor ICP-022

object_name: mantle cell lymphoma


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Airway Remodeling


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:72296

subject_name: Apixaban

object_name: Embolism and thrombosis of the renal vein


subject: CHEBI:72296

object_name: Renal vein thrombosis


subject: CHEBI:72296

object_name: portal vein thrombosis


subject: CHEBI:72296

object_name: Portal Vein Thrombosis, CTCAE


subject: CHEBI:72296

object_name: Hepatic Thrombosis


subject: CHEBI:72296

object_name: Gonadal Thrombosis


subject: CHEBI:72296

object_name: Splenic thrombosis


subject: CHEBI:72296

object_name: Mesenteric thrombosis


subject: CHEBI:72296

object_name: Mesenteric venous thrombosis


subject: CHEBI:72296

object_name: Embolism, Tumor


subject: CHEBI:72296

object_name: Primary malignant neoplasm


subject: CHEBI:72296

object_name: cancer


subject: CHEBI:72296

object_name: childhood malignant neoplasm


subject: CHEBI:72296

object_name: Malignant obstetric neoplasm


subject: CHEBI:151315

subject_name: Heparin


subject: CHEBI:151315


subject: CHEBI:151315


subject: CHEBI:151315


subject: CHEBI:151315


subject: CHEBI:151315

object_name: Cerebral Venous Thrombosis Related to COVID-19


subject: CHEBI:151315

object_name: Cerebral venous thrombosis


subject: CHEBI:151315


subject: CHEBI:151315


subject: CHEBI:151315


subject: CHEBI:151315


subject: CHEBI:151315


subject: CHEBI:151315


subject: GTOPDB:6803

subject_name: dalteparin

object_name: Deep vein thrombosis of lower limb


subject: GTOPDB:6803

object_name: Embolism and thrombosis of the renal vein


subject: GTOPDB:6803

object_name: Renal vein thrombosis


subject: GTOPDB:6803

object_name: portal vein thrombosis


subject: GTOPDB:6803

object_name: Portal Vein Thrombosis, CTCAE


subject: GTOPDB:6803

object_name: Hepatic Thrombosis


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803

object_name: Gonadal Thrombosis


subject: GTOPDB:6803

object_name: Splenic thrombosis


subject: GTOPDB:6803

object_name: Mesenteric thrombosis


subject: GTOPDB:6803

object_name: Mesenteric venous thrombosis


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: lymphoma, non-Hodgkin, familial


subject: PUBCHEM.COMPOUND:3844471

subject_name: Irofulven

object_name: renal carcinoma


subject: PUBCHEM.COMPOUND:3844471

object_name: kidney neoplasm


subject: PUBCHEM.COMPOUND:3844471

object_name: kidney cancer


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: metabolic bone disorder


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:5280

subject_name: Gatifloxacin

object_name: cataract


subject: CHEBI:5280

object_name: Cataract, CTCAE 3.0


subject: CHEBI:5280

object_name: Cataract, CTCAE 5.0


subject: CHEBI:5280

object_name: cataract on exam (physical finding)


subject: CHEBI:3757

subject_name: Clonidine

object_name: post-traumatic stress disorder


subject: CHEBI:8382

subject_name: Prednisone

object_name: atrial fibrillation


subject: CHEBI:8382

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:8382

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:185135

subject_name: Polyvidone

object_name: Granuloma


subject: CHEBI:8347

subject_name: Povidone-iodine


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: UMLS:C1321600

subject_name: Silver nitrate stain


subject: CHEBI:32130

subject_name: Silver nitrate


subject: UMLS:C1161347

subject_name: Argentum nitricum, silver nitrate


subject: CHEBI:231683

subject_name: Anakinra

object_name: allergic contact dermatitis


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: UMLS:C0305689

subject_name: Collagenase Santyl Ointment

object_name: Diabetic foot ulcer


subject: UMLS:C0721719

subject_name: Microlipid

object_name: perinatal necrotizing enterocolitis


subject: UMLS:C0721719

object_name: short bowel syndrome


subject: UMLS:C0721719

object_name: intestinal perforation


subject: UMLS:C0721719

object_name: Premature infant


subject: UMLS:C0721719

object_name: Premature birth


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: Graft failure


subject: CHEBI:135117

subject_name: ftivazide

object_name: multidrug-resistant tuberculosis


subject: CHEBI:6030

subject_name: Isoniazid


subject: UMLS:C3714638

subject_name: Pyridoxine Drug Class


subject: CHEBI:27306

subject_name: vitamin B6


subject: UMLS:C2346811

object_name: Epithelioma


subject: CHEBI:41423

subject_name: Celecoxib

object_name: amyotrophic lateral sclerosis


subject: DRUGBANK:DB01404

subject_name: Ginseng

object_name: hematopoietic and lymphoid system neoplasm


subject: DRUGBANK:DB01404

object_name: Malignant Solid Neoplasm


subject: DRUGBANK:DB14296

subject_name: Panax quinquefolius whole


subject: DRUGBANK:DB14296


subject: UMLS:C0982174

subject_name: Absorbable Gelatin

object_name: Alveolalgia


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab


subject: UNII:52CMI0WC3Y

object_name: Stage III Intrahepatic Cholangiocarcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IV Intrahepatic Cholangiocarcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage III Hepatocellular Carcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IV Hepatocellular Carcinoma AJCC v8


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V

object_name: Unresectable Hepatocellular Carcinoma


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UMLS:C3152625

subject_name: Pneumococcal 13-valent conjugate vaccine


subject: UMLS:C3152625


subject: UMLS:C3152625


subject: UMLS:C3152625


subject: UMLS:C3152625


subject: UMLS:C3152625


subject: UNII:6XG22YQM2Z

subject_name: TIRAGOLUMAB


subject: UNII:6XG22YQM2Z


subject: UNII:6XG22YQM2Z


subject: UNII:6XG22YQM2Z


subject: UNII:6XG22YQM2Z


subject: UNII:6XG22YQM2Z


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C2936067

object_name: HIV infection


subject: CHEBI:231425

subject_name: tolvaptan

object_name: chronic kidney disease


subject: CHEBI:231425

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C0762110


subject: UMLS:C0762110


subject: CHEBI:6427

subject_name: Leuprolide

object_name: castration-resistant prostate carcinoma


subject: PUBCHEM.COMPOUND:6012

subject_name: Durandro

object_name: metastatic prostate carcinoma


subject: PUBCHEM.COMPOUND:6012

object_name: Stage IVB Prostate Cancer AJCC v8


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: UNII:TC549UFL8P

object_name: juvenile idiopathic arthritis


subject: UMLS:C1831848


subject: UNII:Y6BX7BL23K

subject_name: Pemigatinib

object_name: dedifferentiated liposarcoma


subject: UNII:2Y3T5IF01Z

subject_name: Retifanlimab


subject: UMLS:C4688466

subject_name: INCMGA 0012


subject: CHEBI:6741

subject_name: Meloxicam

object_name: rheumatoid arthritis


subject: UMLS:C2937463

subject_name: PERFLUTREN 6.52 mg in 1 mL INTRAVENOUS INJECTION, SUSPENSION [Definity]

object_name: Childhood Breast Carcinoma


subject: UMLS:C2937463

object_name: breast carcinoma


subject: UMLS:C2937463

object_name: breast cancer


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Effects of radiation


subject: UMLS:C0003250

subject_name: Monoclonal Antibodies

object_name: bronchiolitis


subject: UMLS:C5203232

subject_name: Monoclonal Antibody [EPC]


subject: UMLS:C5780016

subject_name: PD-L1/IDO Peptide Vaccine IO102-103

object_name: head and neck squamous cell carcinoma


subject: CHEBI:31498

subject_name: Simethicone

object_name: irritable bowel syndrome


subject: DRUGBANK:DB16693

subject_name: Insulin icodec

object_name: Diabetes


subject: DRUGBANK:DB16693

object_name: diabetes mellitus


subject: GTOPDB:12918


subject: UMLS:C4086733

subject_name: EPO 018B

object_name: anemia


subject: UMLS:C4086733

object_name: Anemia, CTCAE


subject: UMLS:C4086733

object_name: end stage renal failure


subject: UMLS:C4086733

object_name: Chronic uremia


subject: MESH:D061545

subject_name: Carbonated Water

object_name: Postprandial hyperglycemia


subject: MESH:D061545

object_name: type 2 diabetes mellitus


subject: MESH:D061545

object_name: abdominal obesity-metabolic syndrome


subject: MESH:D061545

object_name: metabolic syndrome X


subject: CHEBI:33704

subject_name: Amino acid


subject: CHEBI:33704


subject: CHEBI:33704


subject: PUBCHEM.COMPOUND:169449957

subject_name: Amino Acids


subject: PUBCHEM.COMPOUND:169449957


subject: PUBCHEM.COMPOUND:169449957


subject: CHEMBL.COMPOUND:CHEMBL1201498

subject_name: AMINO ACIDS


subject: CHEMBL.COMPOUND:CHEMBL1201498


subject: CHEMBL.COMPOUND:CHEMBL1201498


subject: UMLS:C3539946

subject_name: Amino Acids, I.V. solution additive


subject: UMLS:C3539946


subject: UMLS:C3539946


subject: UMLS:C0002520


subject: UMLS:C0002520


subject: UMLS:C0002520


subject: UMLS:C3539947

subject_name: Antifibrinolytic amino acids


subject: UMLS:C3539947


subject: UMLS:C3539947


subject: UMLS:C2348261

subject_name: Dietary Chromium


subject: UMLS:C2348261


subject: UMLS:C2348261


subject: CHEBI:28073

subject_name: Chromium


subject: CHEBI:28073


subject: CHEBI:28073


subject: CHEBI:49544

subject_name: Chromic cation


subject: CHEBI:49544


subject: CHEBI:49544


subject: MESH:C000706407

object_name: vulvovaginal candidiasis


subject: UMLS:C3852673

object_name: schizophrenia


subject: PUBCHEM.COMPOUND:25069722


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Plexosarcoma


subject: DRUGBANK:DB16519

subject_name: Zofin

object_name: Chronic obstructive pulmonary disease of horses


subject: DRUGBANK:DB16519

object_name: COPD, severe early onset


subject: DRUGBANK:DB16519

object_name: chronic obstructive pulmonary disease


subject: CHEBI:50634

object_name: angle-closure glaucoma


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEBI:46295

subject_name: Vardenafil


subject: CHEBI:46295


subject: CHEBI:31859

subject_name: Modafinil

object_name: Irritable heart


subject: CHEBI:109549

subject_name: Ramelteon

object_name: bipolar disorder


subject: CHEBI:17858

subject_name: oxiglutatione

object_name: pervasive developmental disorder


subject: CHEBI:17858

object_name: autism


subject: CHEBI:177535

subject_name: L-Glutathione (reduced)


subject: CHEBI:177535


subject: CHEBI:57925


subject: CHEBI:57925


subject: CHEBI:177258

subject_name: Cytidine 2',3'-cyclic phosphate


subject: CHEBI:177258


subject: CHEBI:16856

subject_name: Glutathione


subject: CHEBI:16856


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:7421

subject_name: NAC


subject: CHEBI:7421


subject: PUBCHEM.COMPOUND:40703

subject_name: PINAVERIUM BROMIDE

object_name: chronic pancreatitis


subject: UNII:7SCF54H12J

subject_name: Pinaverium bromide [MI]


subject: CHEBI:135811

subject_name: Pinaverium


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: tuberculosis


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:5103

subject_name: Flumazenil

object_name: Pelvis fracture


subject: CHEBI:5103

object_name: Hip Fracture, CTCAE


subject: CHEBI:5103

object_name: hip fracture


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam


subject: PUBCHEM.COMPOUND:9824461


subject: PUBCHEM.COMPOUND:9824461


subject: CHEBI:57834

object_name: hypertension


subject: CHEBI:57834

object_name: Hypertension, CTCAE


subject: CHEBI:16610

subject_name: Spermidine


subject: CHEBI:16610


subject: CHEBI:70839

subject_name: Dasatinib

object_name: melanoma


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:17026

subject_name: Progesterone

object_name: traumatic encephalopathy


subject: CHEBI:17026

object_name: traumatic brain injury


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: UMLS:C2757070


subject: CHEBI:28911

subject_name: cob(III)alamin

object_name: Pregnant


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: CHEBI:176843

subject_name: vitamin B12


subject: UMLS:C0086024

subject_name: cobalamins


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: CHEBI:50861

subject_name: Treprostinil

object_name: kidney failure


subject: CHEBI:50861

object_name: Renal dysfunction


subject: UMLS:C4705552

object_name: X-linked hypohidrotic ectodermal dysplasia


subject: CHEBI:30879

subject_name: alcohol

object_name: Heat Stress Disorders


subject: CHEBI:30879

object_name: age


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:16236


subject: UMLS:C3854029

subject_name: antiseptics ethanol

object_name: alcohol consumption (history)


subject: UMLS:C3854029


subject: UMLS:C3854029


subject: UMLS:C3854030

subject_name: CNS depressants ethanol


subject: UMLS:C3854030


subject: UMLS:C3854030


subject: UMLS:C0384570

subject_name: Recombinant Human Growth Hormone

object_name: chronic kidney disease


subject: UMLS:C0384570

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C2825029

subject_name: Recombinant Human Growth Hormone [EPC]


subject: UMLS:C2825029


subject: UMLS:C1145196

subject_name: INJECTION, FONDAPARINUX SODIUM, 0.5 MG ADMINISTERED

object_name: Venous thrombosis after immobility


subject: UMLS:C1508862

subject_name: INJECTION, BEVACIZUMAB, 10 MG, Administered

object_name: Pancreatic carcinoma non-resectable


subject: UMLS:C2729368

subject_name: INJECTION, BEVACIZUMAB, 0.25 MG, Administered


subject: UMLS:C5203354

subject_name: Bevacizumab Liquid Injection


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UMLS:C2346815

object_name: neoplasm


subject: CHEBI:94366

subject_name: itraconazole


subject: CHEBI:133017

subject_name: Pimavanserin

object_name: post-traumatic stress disorder


subject: CHEBI:133017

object_name: Chronic Insomnia


subject: CHEBI:143658

object_name: Childhood Hodgkin Lymphoma


subject: UNII:MF4P7VQ2K8

subject_name: TAVOKINOGENE TELSEPLASMID

object_name: trabecular adenocarcinoma


subject: UNII:MF4P7VQ2K8

object_name: cutaneous neuroendocrine carcinoma


subject: UMLS:C5700412

subject_name: Tavo


subject: UMLS:C5700412


subject: UMLS:C0002521

subject_name: Amino Acids, Branched-Chain

object_name: hepatic encephalopathy


subject: UMLS:C0002521

object_name: Acute-On-Chronic Liver Failure


subject: UMLS:C0002521

object_name: acute-on-chronic liver failure


subject: CHEBI:5383

subject_name: Glimepiride

object_name: coronary microvascular disorder


subject: UNII:0JE2QYQ7CW

subject_name: Oliceridine fumarate

object_name: pain agnosia


subject: UNII:0JE2QYQ7CW

object_name: Pain insensitivity


subject: PUBCHEM.COMPOUND:66555030

subject_name: Oliceridine


subject: PUBCHEM.COMPOUND:66555030


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: heart failure


subject: PUBCHEM.COMPOUND:92043599

object_name: Heart Failure, CTCAE


subject: CHEBI:2948

subject_name: Azathioprine

object_name: Parthenium dermatitis


subject: CHEBI:601027

subject_name: Aliskiren

object_name: diabetic macular edema


subject: CHEBI:44915

subject_name: Propofol

object_name: Pruritus, CTCAE


subject: CHEBI:44915

object_name: Pruritus


subject: CHEBI:49086

object_name: uveal melanoma


subject: CHEBI:16436

subject_name: Citicoline


subject: CHEBI:17154

subject_name: Nicotinamide

object_name: polycystic kidney disease


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: rheumatoid arthritis


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: UMLS:C3714638

subject_name: Pyridoxine Drug Class

object_name: epilepsy


subject: UMLS:C3714638

object_name: vitamin B6 measurement


subject: UMLS:C3714638

object_name: Atypical behavior


subject: CHEBI:27306

subject_name: vitamin B6


subject: CHEBI:27306


subject: CHEBI:27306


subject: GTOPDB:9615

object_name: non-Hodgkin lymphoma


subject: UMLS:C3658787


subject: DRUGBANK:DB17530


subject: PUBCHEM.COMPOUND:9831414

subject_name: Lovaza


subject: UNII:D87YGH4Z0Q

subject_name: Omacor


subject: UNII:KXG2PJ551I

subject_name: Avelumab


subject: UMLS:C3896806


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: CHEBI:31348

subject_name: Capecitabine


subject: UMLS:C5777124

subject_name: CD-16 NK-92 cells


subject: UMLS:C4552849

subject_name: haNK


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: UNII:06P3KLK2J8

subject_name: Glofitamab

object_name: mantle cell lymphoma


subject: UMLS:C4725069

subject_name: glofitamab


subject: CHEBI:151315

subject_name: Heparin

object_name: Upper Extremity Deep Vein Thrombosis, Secondary


subject: CHEBI:230519

subject_name: heparin sodium


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Solid Neoplasm


subject: CHEBI:8988

object_name: HER2 positive


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:6801

subject_name: Metformin

object_name: autosomal dominant polycystic kidney disease


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Metastatic Bladder Urothelial Carcinoma


subject: UNII:M89N0Q7EQR

object_name: Unresectable Ureter Urothelial Carcinoma


subject: UNII:M89N0Q7EQR

object_name: Unresectable Renal Pelvis Urothelial Carcinoma


subject: UNII:M89N0Q7EQR

object_name: Urothelial carcinoma ureter metastatic


subject: UNII:M89N0Q7EQR

object_name: Metastatic Urethral Urothelial Carcinoma


subject: UNII:M89N0Q7EQR

object_name: Metastatic Renal Pelvis Urothelial Carcinoma


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:7457

subject_name: Nalmefene

object_name: Disinhibition


subject: CHEBI:7457

object_name: Parkinson disease


subject: CHEBI:85083

subject_name: Sofosbuvir

object_name: male infertility